Assessing health system preparedness for MASLD in the Middle East and North Africa
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) represents an escalating healthcare burden across the Middle East and North...
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) represents an escalating healthcare burden across the Middle East and North...
Houston, TX (November 8, 2025) — Advanced chronic kidney disease (CKD) presents a formidable clinical challenge: determining which patients will...
Credit: CC0 Public Domain It can be challenging to identify which patients with advanced chronic kidney disease (CKD) will most...
Table of Content Liver Cancer Drug Market Revenue and Trends 2025 to 2033 The global liver cancer drug market revenue...
In a groundbreaking study published in the Journal of Medical and Biological Engineering, researchers have taken a significant step forward...
A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and...